337 related articles for article (PubMed ID: 27209351)
21. Endometrial carcinoma first presenting as paraneoplastic cerebellar degeneration.
Erez Y; Rojansky N; Shveiky D; Ben-Meir A; Benshushan A
Gynecol Oncol; 2007 Jun; 105(3):826-7. PubMed ID: 17428523
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic cerebellar degeneration as a presenting manifestation of non-Hodgkin's lymphoma.
Nanda S; Handa R; Prasad A; Anand R; Zutshi D; Dass SK; Bedi PK; Pahuja A; Shah PK; Sharma B; Malhotra N
Neurol Sci; 2021 Jun; 42(6):2523-2525. PubMed ID: 33555484
[TBL] [Abstract][Full Text] [Related]
23. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
Supit W; Mochtar CA; Santoso RB; Umbas R
Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
[TBL] [Abstract][Full Text] [Related]
26. Transurethral Resection of the Bladder Tumour as a Treatment Method in Children with Transitional Cell Carcinoma of the Bladder--Analysis of Our Material and Literature Review.
Apoznański W; Rysiakiewicz J; Polok M; Rysiakiewicz K; Siekanowicz P; Hilger T; Zagierski J; Hilger M; Nowak I; Kolęda P; Szydełko T
Adv Clin Exp Med; 2015; 24(3):505-9. PubMed ID: 26467141
[TBL] [Abstract][Full Text] [Related]
27. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
28. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
29. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
30. Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Manifesting as Acute Cerebellitis with Posterior Cranial Fossa Hypertension.
Enríquez-Marulanda A; Beltrán-Osorio LD; Escobar LA; Granados AM; Velásquez-Lasprilla F; Orozco JL
World Neurosurg; 2018 Apr; 112():117-122. PubMed ID: 29378343
[TBL] [Abstract][Full Text] [Related]
31. Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: factors resulting in pT0 radical cystectomy specimens.
Mazaris E; Nafie S; Boustead G
Int Braz J Urol; 2013; 39(3):364-70. PubMed ID: 23849584
[TBL] [Abstract][Full Text] [Related]
32. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
[TBL] [Abstract][Full Text] [Related]
33. Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors.
Huguet J
Actas Urol Esp; 2013 Jun; 37(6):376-82. PubMed ID: 23611464
[TBL] [Abstract][Full Text] [Related]
34. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
Sanderson KM; Rouprêt M
BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
[TBL] [Abstract][Full Text] [Related]
35. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
36. Surgical management of bladder urothelial carcinoma with squamous differentiation.
Raman JD; Jafri SM
Urol Oncol; 2015 Oct; 33(10):429-33. PubMed ID: 26206104
[TBL] [Abstract][Full Text] [Related]
37. Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma.
Mitchell AN; Bakhos CT; Zimmerman EA
J Clin Neurosci; 2015 Feb; 22(2):421-3. PubMed ID: 25443085
[TBL] [Abstract][Full Text] [Related]
38. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung.
Bruylant K; Crols R; Humbel RL; Appel B; De Deyn PP
Clin Neurol Neurosurg; 2006 Jun; 108(4):415-7. PubMed ID: 16644410
[TBL] [Abstract][Full Text] [Related]
39. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
40. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
